A sensitive LC-MS/MS method for the quantification of serum epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in the identification of diabetic kidney disease
Analytical and Bioanalytical Chemistry · 2025
DOI: 10.1007/s00216-025-05798-z ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, 2025. Verfasst von Yi Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, China-Japan Friendship Hospital, Beijing, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Diabetic Nephropathies, 8,11,14-Eicosatrienoic Acid. Die Arbeit nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Elite Medical Professionals Project of China-Japan Friendship Hospital.
Abstract (Originalsprache)
Epoxyeicosatrienoic acids (EETs) are vasoactive eicosanoids with vasodilatory, anti-inflammatory, and nephroprotective properties, and metabolized to low-bioactive dihydroxyeicosatrienoic acids (DHETs) by soluble epoxide hydrolase. Evidence from animal studies suggests that EETs may be potential biomarkers for diabetic kidney disease (DKD). The aim of this study was to establish a simple, sensitive and accurate LC-MS/MS method for quantifying EETs and DHETs in human serum. Samples were prepared by solid phase extraction and quantified using a "one-to-one" isotope internal standard approach. The assay required a 9-min run time per sample. EETs and DHETs demonstrated good linearity over the investigated concentration range (r2 > 0.99). The limits of quantification were 0.01 ng/mL, with accuracies ranging from 85.62 to 110.95%, intra- and inter-day variations of less than ± 15%, and matrix effects of less than ± 10%. However, 5,6-EET showed poor performance due to chemical instability and low response peaks. We successfully applied this method to rapidly analyze serum samples from 54 patients with diabetes and DKD. Levels of EETs and DHETs were downregulated in DKD patients compared to diabetic patients, and these eicosanoids showed significant negative correlations with proteinuria. This study presented a sensitive and robust LC-MS/MS method for monitoring low levels of EETs and DHETs in human serum and showed the potential for its application in the diagnosis and staging of DKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, China-Japan Friendship Hospital, Beijing, China.
- Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Calibra Scientific, Inc., Hangzhou, China.
- Key Laboratory of Digital Technology in Medical Diagnostics of Zhejiang Province, Calibra Scientific, Inc., Hangzhou, China. jiawei6@zju.edu.cn.
- Department of Clinical Laboratory, China-Japan Friendship Hospital, Beijing, China. caoyongtong100@sina.com.
- Department of Clinical Laboratory, China-Japan Friendship Hospital, Beijing, China. liangma321@163.com.
Förderung
- National Natural Science Foundation of China
- Elite Medical Professionals Project of China-Japan Friendship Hospital
Zitieren
APA
Liu, Y., Huang, A., Jiang, Y., Kong, X., Zhao, M., Gao, P., Yang, M., Kong, Z., Jia, W., Cao, Y., & Ma, L. (2025). A sensitive LC-MS/MS method for the quantification of serum epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in the identification of diabetic kidney disease. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-025-05798-z
Vancouver
Liu Y, Huang A, Jiang Y, Kong X, Zhao M, Gao P, et al. A sensitive LC-MS/MS method for the quantification of serum epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in the identification of diabetic kidney disease. Analytical and Bioanalytical Chemistry. 2025. doi:10.1007/s00216-025-05798-z
BibTeX
@article{Liu2025,
author = {Liu, Yi and Huang, Anxian and Jiang, Yongwei and Kong, Xiaomu and Zhao, Meimei and Gao, Peng and Yang, Ming and Kong, Ziqing and Jia, Wei and Cao, Yongtong and Ma, Liang},
title = {A sensitive LC-MS/MS method for the quantification of serum epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in the identification of diabetic kidney disease},
journal = {Analytical and Bioanalytical Chemistry},
year = {2025},
doi = {10.1007/s00216-025-05798-z}
}
EUVIMED